Co-Diagnostics, Inc. CODX
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -30.74% | -35.25% | -24.59% | 22.05% | 4.20% |
| Total Depreciation and Amortization | -22.49% | -18.48% | -19.63% | -10.26% | 0.16% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,061.71% | 534.71% | 355.42% | -88.83% | -83.77% |
| Change in Net Operating Assets | -328.77% | -148.32% | -214.98% | -169.87% | -65.18% |
| Cash from Operations | 16.59% | 3.98% | 0.06% | -21.27% | -34.06% |
| Capital Expenditure | 50.38% | -71.32% | 6.44% | 43.76% | 38.41% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -93.57% | 138.31% | 51.37% | -0.18% | 14.76% |
| Cash from Investing | -94.68% | 142.09% | 53.91% | 1.70% | 17.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,939.50% | 3,343.44% | 11,268.24% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,939.50% | 3,343.44% | 11,268.24% | 3,197.12% | 372.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -172.10% | 129.85% | 174.69% | 15.87% | -9,864.06% |